Bio-Rad Laboratories Inc
Fechado
SetorSaúde
278.8 2.85
Visão Geral
Variação de preço das ações
24h
Mín
269.92
Máximo
283.35
Rendimento | -731M -11M |
|---|---|
Vendas | -101M 592M |
P/E Médio do Setor | 46.696 50.958 |
EPS | 1.89 |
Margem de lucro | -1.858 |
Funcionários | 7,450 |
EBITDA | -751M -637M |
Recomendações | Neutro |
|---|---|
Previsão para 12 meses | +11.44% upside |
Próximos Ganhos | 30 de jul. de 2026 |
|---|
Capitalização de Mercado | -235M 7.5B |
|---|---|
Abertura anterior | 275.95 |
Fecho anterior | 278.8 |
Sentimento de Notícias
By Acuity
50%
50%
146 / 342 Ranking em Healthcare
Bio-Rad Laboratories Inc Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Sobre Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.